Clinical trial
Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With…
NCT04026165 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT04026165 |
|---|---|
| Title | Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease |
| Official title | MOSAIC - A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects With Moderate to Advanced Diabetic Kidney Disease |
| Acronym | MOSAIC |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Kidney Disease |
| Intervention type | Drug |
| Interventions | SEL, Placebo |
| Enrollment | 384 |
| Start date | Jul 24, 2019 |
| Primary completion | Sep 3, 2021 |
| Completion | Sep 3, 2021 |
| First posted | Jul 19, 2019 |
| Last update posted | Dec 21, 2022 |
| Countries | Australia, Canada, Japan, New Zealand, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: